Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Risk-Adapted Stanford V-C With Radiotherapy for Clinical Stage I and IIA Favorable Hodgkin's Disease: The G5 Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00026208
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:51.975794+00:00
Published At
2018-05-15T00:00:00+00:00
Record Updated At
2018-07-24
Results Posted At
2018-05-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphoma, Hodgkin Disease", "Lymphoma", "Hodgkin Disease", "Lymphoma: Hodgkin"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-07-24"
protocolSection.identificationModule.nctId
"NCT00026208"
protocolSection.identificationModule.officialTitle
"Risk-Adapted Stanford V-C With Radiotherapy for Clinical Stage I and IIA Favorable Hodgkin\u0027s Disease: The G5 Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-05-15"

Study condition terms

  • Lymphoma, Hodgkin Disease (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Hodgkin Disease (protocolSection.conditionsModule.conditions)
  • Lymphoma: Hodgkin (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.